Ameriprise
PRAH

Ameriprise’s PRA Health Sciences, Inc. PRAH Stock Holding History

Ameriprise’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-115,450
Closed -$19.1M – 4028
2021
Q2 		$19.1M Sell
115,450
-46,245
-29% -$7.72M 0.01% 1398
2021
Q1 		$24.8M Sell
161,695
-311,966
-66% -$42.4M 0.01% 1167
2020
Q4 		$59.4M Sell
473,661
-25,016
-5% -$2.8M 0.02% 667
2020
Q3 		$50.6M Sell
498,677
-451,191
-48% -$46M 0.02% 637
2020
Q2 		$92.4M Sell
949,868
-46,127
-5% -$4.29M 0.04% 415
2020
Q1 		$82.7M Sell
995,995
-222,259
-18% -$21.7M 0.04% 385
2019
Q4 		$135M Buy
1,218,254
+281,642
+30% +$29M 0.06% 323
2019
Q3 		$92.9M Sell
936,612
-52,556
-5% -$5.22M 0.04% 429
2019
Q2 		$98.1M Buy
989,168
+289,416
+41% +$27.6M 0.04% 429
2019
Q1 		$77.2M Sell
699,752
-58,077
-8% -$6.07M 0.04% 494
2018
Q4 		$69.7M Sell
757,829
-473,677
-38% -$47.9M 0.03% 500
2018
Q3 		$136M Sell
1,231,506
-361,528
-23% -$37.6M 0.05% 363
2018
Q2 		$149M Buy
1,593,034
+19,184
+1% +$1.65M 0.07% 302
2018
Q1 		$131M Buy
1,573,850
+736,432
+88% +$65.4M 0.06% 314
2017
Q4 		$76.3M Buy
837,418
+3,384
+0.4% +$281K 0.03% 443
2017
Q3 		$63.5M Buy
834,034
+45,227
+6% +$3.42M 0.03% 489
2017
Q2 		$59.2M Buy
788,807
+147,428
+23% +$10.2M 0.03% 499
2017
Q1 		$41.8M Buy
641,379
+429,621
+203% +$25.3M 0.02% 611
2016
Q4 		$11.7M Buy
211,758
+44,778
+27% +$2.46M 0.01% 1412
2016
Q3 		$9.44M Buy
166,980
+18,124
+12% +$889K 0.01% 1501
2016
Q2 		$6.22M Sell
148,856
-54,044
-27% -$2.49M ﹤0.01% 1771
2016
Q1 		$8.68M Buy
+202,900
New +$8.57M 0.01% 1541

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Ameriprise's PRAH Position: Q3 2021 in Review

Ameriprise sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 115,450 shares — an estimated $19.1M sold.

Ameriprise first reported a position in PRAH in Q1 2016 and held it in 22 quarters. The position peaked at $149M in Q2 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Ameriprise reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Ameriprise sold 115,450 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $19.1M.
  • Ameriprise first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 22 quarters.
  • Ameriprise's PRA Health Sciences, Inc. position peaked at $149M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Ameriprise's 13F filing for Q3 2021, filed 15 Nov 2021.